These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 9164433

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Suspected complication of treatment with venlafaxine.
    Wilson R, Jenkins P.
    J Clin Psychopharmacol; 1997 Aug; 17(4):323. PubMed ID: 9241015
    [No Abstract] [Full Text] [Related]

  • 25. SIADH with multiple antidepressants in a geriatric patient.
    Blass DM, Pearson VE.
    J Clin Psychiatry; 2000 Jun; 61(6):448-9. PubMed ID: 10901346
    [No Abstract] [Full Text] [Related]

  • 26. Cyproheptadine for drug-induced sweating.
    Ashton AK, Weinstein WL.
    Am J Psychiatry; 2002 May; 159(5):874-5. PubMed ID: 11986151
    [No Abstract] [Full Text] [Related]

  • 27. A case of venlafaxine-induced inhibition of T-lymphocyte proliferation.
    Denys D, Kavelaars A, Heijnen CJ, Westenberg H.
    Psychopharmacology (Berl); 2002 Dec; 164(4):432. PubMed ID: 12457275
    [No Abstract] [Full Text] [Related]

  • 28. A possible case of venlafaxine-induced Stevens-Johnson syndrome.
    Weiss NT, Jones L, Chamberlain JC.
    J Clin Psychiatry; 2004 Oct; 65(10):1431-3. PubMed ID: 15491252
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Successful duloxetine use to prevent venlafaxine withdrawal symptoms.
    Hsiao MC, Liu CY.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):576. PubMed ID: 17889418
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Venlafaxine and reversible blepharoedema.
    Reif A, Pfuhlmann B.
    Int J Neuropsychopharmacol; 2002 Dec 15; 5(4):413-4. PubMed ID: 12466039
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Safety and tolerability of the new antidepressants.
    Nelson JC.
    J Clin Psychiatry; 1997 Dec 15; 58 Suppl 6():26-31. PubMed ID: 9227670
    [Abstract] [Full Text] [Related]

  • 36. Clinical evaluation of venlafaxine.
    Ballenger JC.
    J Clin Psychopharmacol; 1996 Jun 15; 16(3 Suppl 2):29S-35S; discussion 35S-36S. PubMed ID: 8784646
    [Abstract] [Full Text] [Related]

  • 37. Late-onset galactorrhea and menometrorrhagia with venlafaxine use in a migraine patient.
    Berilgen MS.
    J Clin Psychopharmacol; 2010 Dec 15; 30(6):753-4. PubMed ID: 21057247
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.